Vanguard Group Inc. Decreases Position in Plexus Corp. $PLXS

Vanguard Group Inc. lessened its holdings in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 1.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 3,632,761 shares of the technology company’s stock after selling 51,084 shares during the quarter. Vanguard Group Inc. owned about 0.14% of Plexus worth $534,016,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in PLXS. American Century Companies Inc. increased its stake in shares of Plexus by 44.2% in the third quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after purchasing an additional 338,119 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in shares of Plexus by 23.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 240,192 shares of the technology company’s stock worth $34,753,000 after purchasing an additional 45,425 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Plexus by 28.3% in the third quarter. JPMorgan Chase & Co. now owns 240,460 shares of the technology company’s stock worth $34,792,000 after purchasing an additional 52,967 shares in the last quarter. Nicola Wealth Management LTD. purchased a new stake in shares of Plexus in the third quarter worth $6,655,000. Finally, Fieldview Capital Management LLC purchased a new stake in shares of Plexus in the third quarter worth $1,999,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Insider Buying and Selling at Plexus

In other Plexus news, COO Oliver K. Mihm sold 9,541 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total transaction of $1,921,557.40. Following the completion of the transaction, the chief operating officer owned 12,809 shares in the company, valued at $2,579,732.60. This trade represents a 42.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Todd P. Kelsey sold 5,231 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $195.78, for a total transaction of $1,024,125.18. Following the transaction, the chief executive officer owned 83,291 shares of the company’s stock, valued at $16,306,711.98. This trade represents a 5.91% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 32,108 shares of company stock valued at $6,474,274 over the last ninety days. Corporate insiders own 1.78% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on PLXS shares. Needham & Company LLC increased their price objective on shares of Plexus from $206.00 to $285.00 and gave the stock a “buy” rating in a research note on Friday. Weiss Ratings cut shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, April 24th. Benchmark reissued a “buy” rating and issued a $220.00 price objective on shares of Plexus in a research note on Monday, March 16th. Raymond James Financial reissued an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a research note on Thursday. Finally, Williams Trading set a $195.00 price objective on shares of Plexus in a research note on Wednesday, January 28th. Five analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $229.17.

Check Out Our Latest Research Report on PLXS

Plexus Price Performance

Shares of NASDAQ:PLXS opened at $262.55 on Tuesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54. The firm has a fifty day moving average price of $211.79 and a 200 day moving average price of $179.04. Plexus Corp. has a fifty-two week low of $115.35 and a fifty-two week high of $272.08. The firm has a market cap of $7.03 billion, a price-to-earnings ratio of 38.38 and a beta of 0.88.

Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, beating the consensus estimate of $1.87 by $0.18. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The business had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same quarter last year, the business earned $1.66 earnings per share. Plexus’s quarterly revenue was up 18.7% compared to the same quarter last year. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, sell-side analysts expect that Plexus Corp. will post 6.56 earnings per share for the current fiscal year.

About Plexus

(Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

See Also

• Five stocks we like better than Plexus

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).